Your browser doesn't support javascript.
loading
Analytical evaluation and Sigma metrics of 6 next generation chemistry assays on the Abbott Architect system.
Ren, Annie; Wang, Xiao Yan; Cheng, Pow Lee; Brinc, Davor; Berman, Marvin I; Kulasingam, Vathany.
Afiliación
  • Ren A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
  • Wang XY; Division of Clinical Biochemistry, University Health Network, Toronto, Canada.
  • Cheng PL; Division of Clinical Biochemistry, University Health Network, Toronto, Canada.
  • Brinc D; Division of Clinical Biochemistry, University Health Network, Toronto, Canada.
  • Berman MI; Abbott Laboratories, Abbott Park, IL, United States.
  • Kulasingam V; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada; Division of Clinical Biochemistry, University Health Network, Toronto, Canada. Electronic address: vathany.kulasingam@uhn.ca.
Clin Chim Acta ; 542: 117276, 2023 Mar 01.
Article en En | MEDLINE | ID: mdl-36870521
BACKGROUND: We evaluated analytical and Sigma performance for 6 next generation chemistry assays on the Abbott Architect c8000 system. METHODS: Albumin with bromocresol purple or green, amylase, cholesterol, total protein, and urea nitrogen were analyzed using photometric technology. Analytical performance goals were defined based on Accreditation Canada Diagnostics (ACD) and Clinical Laboratory Improvement Amendments (CLIA). Precision study consisted of testing 2 quality control concentrations and 3 patient serum sample pools, twice a day in quintuplicate over 5 days. Linearity testing consisted of 5-6 concentrations of commercial linearity materials. We tested a minimum of 120 serum/plasma specimens on the new and current Architect methods for comparison. We assessed accuracy with reference materials for 5 assays, and a calibration standard for cholesterol. Bias from the reference standard target value was used for Sigma metric analysis. RESULTS: Observed total imprecision of the assays ranged from 0.5 to 4%, meeting pre-defined goals. Linearity was acceptable over the tested range. Measurements on the new and current Architect methods were comparable. Accuracy ranged from 0 to 2.0% absolute mean difference from target value. All 6 next generation clinical chemistry assays demonstrated Six Sigma quality, using CLIA standards. CONCLUSION: Applying ACD recommendations, 5 assays showed Six Sigma, while cholesterol showed Five Sigma performance.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Química Clínica / Gestión de la Calidad Total Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Clin Chim Acta Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Química Clínica / Gestión de la Calidad Total Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Clin Chim Acta Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Países Bajos